USD0.000æéå€ååŒÂ  (ET)
10.03BæäŸ¡ç·é¡
20.33çŽè¿12ã¶æPER
Dr Reddy's Laboratories Ltd
äž»èŠããŒã¿
11.800å§å€
11.860é«å€
3.01Måºæ¥é«
20.33çŽè¿12ã¶æPER
25.97äºæ³PER
0.091çŽè¿12ã¶æé
åœ
0.36%売買å転ç
11.830忥çµå€
11.720å®å€
16.94M売買代é
14.75æ ªäŸ¡åçç
2.45PBRïŒæ ªäŸ¡çŽè³ç£åçïŒ
0.76%çŽè¿12ã¶æé
åœå©åã
8.03%ç·è³ç£å©çç
16.17052é±é«å€
0.98åºæ¥é«æ¯ç%
668.95MçŽå©ç
832.69Mæ ªåŒæ°
0.58281æ ªåœããå©çïŒEPSïŒ
0.27ããŒã¿å€
12.23%èªå·±è³æ¬å©çç
12.18552é±å®å€
1.18%æ¯ãå¹
46.52%ç²å©çç
10.03BæäŸ¡ç·é¡
-15.69ãªã¹ã¯ãªã¿ãŒã³
1.13%ãªã¹ã¯ç
é貚: USD æŽæ°æå»: 2026-07-31 äž»èŠã€ã³ãµã€ã
Dr Reddy's Laboratories Ltdã®ãã¡ã³ãã¡ã³ã¿ã«ãºã¯æ¯èŒçå®å®ã§ããæé·ã®å¯èœæ§ã¯é¡èã§ããããªã¥ãšãŒã·ã§ã³ã¯é©æ£äŸ¡æ Œãšè©äŸ¡ãããŠããŸããå»è¬åæ¥çã§ã®é äœã¯155äž82äœã§ããæ©é¢æè³å®¶ä¿æçã¯éåžžã«é«ãã§ããéå»1ãæéã«è€æ°ã®ã¢ããªã¹ããããŒã«ããšè©äŸ¡ããæé«ç®æšæ ªäŸ¡ã¯13.56ãšãããŠããŸããäžæçã«ã¯ãæ ªäŸ¡ã¯äžéãã¬ã³ããšäºæ³ãããŸããåç€Ÿã®æ ªåŒåžå Žã§ã®ããã©ãŒãã³ã¹ã¯éå»1ãæã§éåžžã«äœèª¿ã§ããããã¡ã³ãã¡ã³ã¿ã«ãºãšãã¯ãã«ã«ãåæ§ã«äœæ°Žæºã§ããæ ªäŸ¡ã¯æ¯æç·ã𿵿ç·ã®éã§æšªã°ãæšç§»ããŠãããã¬ã³ãžçžå Žã§ã®ã¹ã€ã³ã°ãã¬ãŒãã«é©ããŠããŸãã
Dr Reddy's Laboratories Ltdã®ã¹ã³ã¢î°î°
ãµããŒãã©ã€ã³ãšã¬ãžã¹ã¿ã³ã¹ã©ã€ã³

äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
éåžžã«äœã
éåžžã«é«ã
Dr Reddy's Laboratories Ltdã®æ³šç®ãã€ã³ã
匷ã¿ãªã¹ã¯
Dr Reddy's Laboratories Ltd ãã¥ãŒã¹
ææ°æ
å ±ããåŸ
ã¡ãã ãã...
åçäºæž¬î
匷åè²·ã
è²·ã
äžç«
売ã
匷å売ã
Dr Reddy's Laboratories Ltd
RDY
4
ææšî
ææš
売ã(3)
äžç«(3)
è²·ã(0)
ç§»åå¹³å
売ã(5)
äžç«(0)
è²·ã(1)
è²¡åææšî
EPS

äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
ç·å£²äžé«

äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
Dr Reddy's Laboratories Ltdã®äŒæ¥æ
å ±î
Dr. Reddyâs Laboratories Limited is an India-based pharmaceutical company. Its products and services are spread across its core businesses of active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars and over-the-counter (OTC) pharmaceutical products. It works in the areas of gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Its segments consist of Global Generics; Pharmaceutical Services and Active Ingredients (PSAI), and Others. The Global Generics segment consists of the Company's business of manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics). The Pharmaceutical Services and Active Ingredients segment consists of the Company's business of manufacturing and marketing APIs and intermediates.
äŒæ¥ã³ãŒãRDY
äŒæ¥åDr Reddy's Laboratories Ltd
æé«çµå¶è²¬ä»»è
ãCEOãAghanian (Patrick)
ãŠã§ããµã€ãhttps://www.drreddys.com/
æ ªäž»çµ±èšî
ãããã質å
Dr Reddy's Laboratories LtdïŒRDYïŒã®çŸåšã®æ ªäŸ¡ã¯ãããã§ããïŒ
îDr Reddy's Laboratories LtdïŒRDYïŒã®çŸåšã®æ ªäŸ¡ã¯11.85ã§ãã
Dr Reddy's Laboratories Ltdã®ãã£ãã«ãŒã·ã³ãã«ã¯äœã§ããïŒ
îDr Reddy's Laboratories Ltdã®ãã£ãã«ãŒã·ã³ãã«ã¯RDYã§ãã
Dr Reddy's Laboratories Ltdã®52é±é«å€ã¯ãããã§ããïŒ
îDr Reddy's Laboratories Ltdã®52é±é«å€ã¯16.17ã§ãã
Dr Reddy's Laboratories Ltdã®52é±å®å€ã¯ãããã§ããïŒ
îDr Reddy's Laboratories Ltdã®52é±å®å€ã¯12.19ã§ãã
Dr Reddy's Laboratories Ltdã®æäŸ¡ç·é¡ã¯ãããã§ããïŒ
îDr Reddy's Laboratories Ltdã®æäŸ¡ç·é¡ã¯9.87Bã§ãã
Dr Reddy's Laboratories Ltd (RDY) ã®çŸåšã®è©äŸ¡ã¯ãè²·ããããããŒã«ãããã売ããã®ã©ãã§ããïŒ
îã¢ããªã¹ãã«ãããšãDr Reddy's Laboratories LtdïŒRDYïŒã®ç·åè©äŸ¡ã¯signal_holdã§ãç®æšæ ªäŸ¡ã¯13.56ã§ãã
Dr Reddy's Laboratories Ltd (RDY) ã®1æ ªåœããå©çïŒEPS TTMïŒã¯ãããã§ããïŒ
îDr Reddy's Laboratories LtdïŒRDYïŒã®1æ ªåœããå©çïŒEPS TTMïŒã¯0.58ã§ãã